Authors
1 Department of Research, Research Institute for Islamic and Complementary Medicine, Iran University of Medical Sciences, Tehran, Iran
2 School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Health Metrics Research Center, Iranian Institute for Health Sciences Research, ACECR, Tehran, Iran
4 Iranian Traditional Medicine, Research Institute for Islamic and Complementary Medicine, Iran University of Medical Sciences, Tehran, Iran
Abstract
Objective: The extent to which a person’s health‑related behavior corresponds with
medical instructions (adherence) is an important modifier of health system effectiveness.
This study was designed to determine the patients’ adherence to Iranian traditional
medicine in a group of patients with chronic disease.
Methods: Convenience sampling was used to enroll 320 patients with chronic diseases
from January 2014 to January 2015 in clinics of traditional medicine affiliated with
medical universities in Tehran. Morisky Medication Adherence Scale (MMAS) was
used to measure the adherence. After describing the variables and the frequency of
adherence, logistic regression analysis was used to determine the influencing factors.
Findings: Mean age was 40.8 (standard deviation [SD] =13) years. The mean of the
duration of disease was 54.6 (SD = 56.1) months and mean of the duration of referring to
the clinics 6.5 (SD = 6.9) months. Total score of MMAS was zero in 33 (10.3%) of patients
(high adherence), one or two in 128 (40%) of patients (moderate adherence), and more
than two in 159 (49.7%) of patients (low adherence). Forgetfulness, bad taste, not
availability, and the high cost of the drugs were the most commonly reported causes of
non‑adherence. Adherence was associated with age(odds ratio[OR] =1.05, 95% confidence
interval [95% CI] 1–1.1), marriage (OR = 10.8, 95% CI 2.05–57.6), number of prescribed
drugs (OR = 0.05, 95% CI 0.02–0.14), and duration of disease (OR = 1.01, 95% CI 1–1.02).
Conclusion: Considering the low adherence in users of medications of Iranian traditional
medicine, health care practitioners need to be trained in adherence and the influencing
factors and also to use some interventions to increase the adherence.
Keywords
- Sabaté E. Adherence to Long‑Term Therapies; Evidence for
Action. Geneva: World Health Organization; 2003. p. 3, 28. - 2. Bani Asad MH, Pana MV, Hemmati M. Studying the belief of
borderline personality disorder patient about the necessity of
medication and the role of demographic factors in adherence
to treatment. Am J Appl Psychol 2014;2:104‑8.
3. Morisky DE, Ang A, Krousel‑Wood M, Ward HJ. Predictive
validity of a medication adherence measure in an outpatient
setting. J Clin Hypertens (Greenwich) 2008;10:348‑54.
4. Burnier M, Santschi V, Favrat B, Brunner HR. Monitoring
compliance in resistant hypertension: An important step in
patient management. J Hypertens Suppl 2003;21:S37‑42.
5. Lagi A, Rossi A, Passaleva MT, Cartei A, Cencetti S.
Compliance with therapy in hypertensive patients. Intern
Emerg Med 2006;1:204‑8.
6. Nuesch R, Schroeder K, Dieterle T, Martina B, Battegay E.
Relation between insufficient response to antihypertensive
treatment and poor compliance with treatment: A prospective
case‑control study. BMJ 2001;323:142‑6.
7. Smith WE. Role of a pharmacist in improving rational drug
therapy as part of the patient care team. Ann Pharmacother
2007;41:330‑5.
8. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient
adherence and medical treatment outcomes: A meta‑analysis.
Med Care 2002;40:794‑811.
9. Cunico C, Picheth G, Correr CJ, Scartezini M. Assessing
the adherence to and the therapeutic effectiveness of
hypolipidemic agents in a population of patients in Brazil:
A retrospective cohort study. Pharm Pract (Granada)
2014;12:378.
10. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki
RT, Varney J, et al. A meta‑analysis of the association between
adherence to drug therapy and mortality. BMJ 2006;333:15.
11. Mar J, Rodríguez‑Artalejo F. Which is more important for the
efficiency of hypertension treatment: Hypertension stage, type
of drug or therapeutic compliance? J Hypertens 2001;19:149‑55.
12. Horne R, Weinman J. Patients’ beliefs about prescribed
medicines and their role in adherence to treatment in chronic
physical illness. J Psychosom Res 1999;47:555‑67.
13. Dunbar‑Jacob J, Erlen JA, Schlenk EA, Ryan CM, Sereika SM,
Doswell WM. Adherence in chronic disease. Annu Rev Nurs
Res 2000;18:48‑90.
14. Morisky DE, Green LW, Levine DM. Concurrent and
predictive validity of a self‑reported measure of medication
adherence. Med Care 1986;24:67‑74.
15. Cramer JA. A systematic review of adherence with medications
for diabetes. Diabetes Care 2004;27:1218‑24.
16. Barreto Mda S, Reiners AA, Marcon SS. Knowledge about
hypertension and factors associated with the non‑adherence
to drug therapy. Rev Lat Am Enfermagem 2014;22:491‑8.
17. Heydari A, Ziaee ES, Gazrani A. Relationship between
awareness of disease and adherence to therapeutic regimen
among cardiac patients. Int J Community Based Nurs
Midwifery 2015;3:23‑30.
18. Shalansky SJ, Levy AR, Ignaszewski AP. Self‑reported Morisky
score for identifying nonadherence with cardiovascular
medications. Ann Pharmacother 2004;38:1363‑8.
19. Erickson SR, Coombs JH, Kirking DM, Azimi AR. Compliance
from self‑reported versus pharmacy claims data with
metered‑dose inhalers. Ann Pharmacother 2001;35:997‑1003.
20. Al‑Qazaz HK, Hassali MA, Shafie AA, Sulaiman SA, Sundram
S, Morisky DE. The eight‑item Morisky Medication Adherence
Scale MMAS: Translation and validation of the Malaysian
version. Diabetes Res Clin Pract 2010;90:216‑21.
21. Sakthong P, Chabunthom R, Charoenvisuthiwongs R.
Psychometric properties of the Thai version of the 8‑item
Morisky Medication Adherence Scale in patients with type 2
diabetes. Ann Pharmacother 2009;43:950‑7.
22. Wang Y, Lee J, Toh MP, Tang WE, Ko Y. Validity and reliability
of a self‑reported measure of medication adherence in patients
with type 2 diabetes mellitus in Singapore. Diabet Med
2012;29:e338‑44.
23. Tzeng JI, Chang CC, Chang HJ, Lin CC. Assessing analgesic
regimen adherence with the Morisky Medication Adherence
Measure for Taiwanese patients with cancer pain. J Pain
Symptom Manage 2008;36:157‑66.
24. Osterberg L, Blaschke T. Adherence to medication. N Engl J
Med 2005;353:487‑97.
25. Hashem Dabaghian F, Karbakhsh M, Soheilikhah S, Sedaghat
M. Drug compliance in type 2 diabetic patients. Payesh
2006;4:103‑11.
26. Gottlieb S, Behar S, Schwartz R, Harpaz D, Shotan A, Zahger D,
et al. Age differences in the adherence to treatment guidelines
and outcome in patients with ST‑elevation myocardial
infarction. Arch Gerontol Geriatr 2011;52:118‑24.
27. Tiv M, Viel JF, Mauny F, Eschwège E, Weill A, Fournier C, et
al. Medication adherence in type 2 diabetes: The ENTRED
study 2007, a French population‑based study. PLoS One
2012;7:e32412.
28. Donnan PT, MacDonald TM, Morris AD. Adherence to
prescribed oral hypoglycaemic medication in a population
of patients with type 2 diabetes: A retrospective cohort study.
Diabet Med 2002;19:279‑84.
29. Sohi H, Sultana Y, Khar RK. Taste masking technologies in
oral pharmaceuticals: Recent developments and approaches.
Drug Dev Ind Pharm 2004;30:429‑48.
30. Fairman K, Motheral B. Evaluating medication adherence:
Which measure is right for your program? J Manag Care
Pharm 2000;6: 499-506.
31. Grymonpre RE, Didur CD, Montgomery PR, Sitar DS. Pill
count, self‑report, and pharmacy claims data to measure
medication adherence in the elderly. Ann Pharmacother
1998;32:749‑54.
32. Gordis L, Markowitz M, Lilienfeld AM. The inaccuracy in
using interviews to estimate patient reliability in taking
medications at home. Med Care 1969;7:49‑54.
33. Anonymous. Just what the doctor ordered; a system approach
to assessing patient adherence. USA: Pfizer Medical Education
Group; 2008. Available from: http://www.ipmameded.org/
media/46347/adherence.pdf.
34. Ravi S, Nasiri Toosi M, Karimzadeh I, Ahadi‑Barzoki M,
Khalili H. Adherence to chronic hepatitis C treatment
regimen: First report from a referral center in Iran. Hepat Mon
2013;13:e11038.
35. Nieuwkerk PT, Oort FJ. Self‑reported adherence to
antiretroviral therapy for HIV‑1 infection and virologic
treatment response: A meta‑analysis. J Acquir Immune Defic
Syndr 2005;38:445‑8.
)